Skip to main content
. 2017 Apr 10;14(4):360–369. doi: 10.1177/1479972317702139

Table 3.

Treatment.

Overall (n = 2099) Men (n = 974) Women (n = 1125) p value
Oral antibiotics
(n = 2013) (n = 935) (n = 1078) 0.07
 No 1645 (81.7) 776 (83.0) 869 (80.6)
 Continuous 77 (3.8) 26 (2.8) 51 (4.7)
 Cyclic 291 (14.5) 133 (14.2) 158 (14.7)
Inhaled antibiotics
(n = 1954) (n = 911) (n = 1043) 0.58
 No 1586 (81.2) 731 (80.2) 855 (82.0)
 Continuous 273 (14.0) 132 (14.5) 141 (13.5)
 Periodic 95 (4.9) 48 (5.3) 47 (4.5)
Inhaled bronchodilators
(n = 1986) (n = 919) (n = 1067) 0.08
 n (%) 1519 (76.5) 720 (78.3) 799 (74.9)
Inhaled corticosteroids
(n = 1961) (n = 909) (n = 1052) 0.55
n (%) 1336 (68.1) 626 (68.9) 710 (67.5)